<DOC>
	<DOCNO>NCT01735201</DOCNO>
	<brief_summary>This study evaluate safety efficacy 3 dose AGN-199201 twice daily compare vehicle treatment moderate severe facial erythema associate rosacea .</brief_summary>
	<brief_title>AGN-199201 Treatment Erythema With Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Erythema</mesh_term>
	<criteria>Redness skin cause rosacea â‰¥3 inflammatory lesion Laser lightsource energy base therapy last 6 month Any prescription counter product treatment acne rosacea last 14 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>